Viropro, Inc (VPRO)
Viropro, Inc. engages in the development of two lines of therapeutic proteins, including cytokines, such as interferon's alpha, G-CSF, erythropoietin and interleukins used in treatment of cancers, multiple sclerosis, hepatitis, and chronic renal failure; and monoclonal antibodies, such as anti-cd20.
Total Income, Quarterly
Profit margin
Net income
Revenue / Net income
Short Term
Long Term
 Accounts payable
Chart
 Short current long term debt
Chart
  Cash and cash equivalents
Chart
 Net receivables
Chart
 Other current assets
Chart
    Property plant and equipment
Chart
  Intangible assets
Chart
Short Term
Long Term
Social Bookmarking 
Research Report
Hotstocked.com has a complete research report available for VPRO stock.
Download VPRO report.
Research Report
Get the full report for FREE
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
